[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"testicular-germ-cell-cancer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:testicular-germ-cell-cancer":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100628582","evaluation-of-bile-acid-concentrations-and-their-signaling-as-markers-of-testicular-tumorigenesis-and-germ-cell-tumor-chemosensitivity-100628582",false,"NCT07463508","Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity","Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity (TG-BIL)","TG-BIL","Inclusion Criteria:\n\n* Adult patient, male, with a clinical and biological diagnosis of germ cell tumor of the testis in pre-orchidectomy, at the stage of the disease and any histological subtype of germ cell tumor\n* Affiliation with a Social Security organization\n* Able to give informed consent to participate in the research.\n\nExclusion Criteria:\n\n* Patient with a hepatobiliary pathology\n* Patient treated with Colestyramine\n* Patient who has undergone cholecystectomy or extensive resection of the small intestine\n* Patient deprived of liberty\n* Patient under guardianship, curatorship, or legal protection\n* Patient unable to understand the protocol (language barrier, cognitive difficulties)\n* Patient with another active cancer\n* Patient participating in a therapeutic clinical trial\n* Refusal to participate","MALE","18 Years",{"count":20,"type":21},20,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.",[27],"Testicular Germ Cell Cancer",[29,30,31],"biomarker","acid biliary","testicular germ cell cancer","RECRUITING","2026-03-05",{"date":35,"type":36},"2026-03-11","ACTUAL",{"date":38,"type":36},"2026-01-01",{"date":40,"type":21},"2029-01-01",{"name":42,"class":43},"University Hospital, Clermont-Ferrand","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100432662","microrna-as-markers-in-testicular-cancer-100432662","NCT04914026","MicroRNA as Markers in Testicular Cancer","MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours","Inclusion Criteria:\n\n* Patients with suspected testicular cancer, referred to orchiectomy.\n* Patients diagnosed with testicular germ cell cancer.\n* Age 18-70 years of age.\n* Must be able receive information and to consent.\n\nExclusion Criteria:\n\n* Other prior or concomitant malignancy (other than testicular cancer).\n* Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.","70 Years",{"count":54,"type":21},350,"OBSERVATIONAL","The main objective of this study is establish the performance of miR371 in management of testicular cancer",[27,58,59,60,61,62,63,64],"Seminoma","Non-Seminoma Testicular Cancer","Stage I Testicular Cancer","Stage II Testicular Cancer","Stage III Testicular Cancer","Stage IV Testicular Cancer","Relapse Testicular Cancer","2022-08-05",{"date":67,"type":36},"2022-08-08",{"date":69,"type":36},"2016-12-31",{"date":71,"type":21},"2026-12-31",{"name":73,"class":43},"Haukeland University Hospital",6]